Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
GTHX | G1 Therapeutics, Inc. | Cfo | $170K | Jan 3, 2023 | ||
VRDN | Viridian Therapeutics, Inc.\DE | Director | Jun 26, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|